Standard treatments can significantly lower the risk of stroke in children with sickle cell anemia, according to a review of ...

The answer is "it should be," says columnist. That way, sickle cell patients could receive the support that they need.

Winter is one of columnist Michelle Harlan's favorite seasons, but having sickle cell disease means navigating this time of ...

A $3 million donation from Big Nova supports NMDP programs that reduce barriers to blood stem cell transplants.

A lack of accessibility in a non-inclusive society for those with a disability comes at a terrible cost, writes columnist.

A Phase 1b trial shows the higher dose of pociredir boosts fetal hemoglobin levels in adults with sickle cell disease.

Risto-cel, a gene-edited cell therapy formerly called BEAM-101, for severe SCD, benefits patients for nearly two years, new ...

A European Medicines Agency committee has issued a positive opinion on the gene-editing therapy Casgevy (exagamglogene autotemcel) in treating sickle cell disease (SCD) and transfusion-dependent beta ...

The Phase 1/2 CLIMB-SCD-121 trial (NCT03745287) is currently evaluating the safety and effectiveness of a single infusion of CTX001 in adults up to age 35 with severe SCD. Two patients have been dosed ...

A student at Kennesaw State University in Georgia is helping to develop a low-cost, light-based device to screen for stroke in children with sickle cell disease (SCD) by monitoring how well their ...

Sickle cell disease (SCD) may be cured in some individuals by a stem cell transplant. There also are several approved therapies to help manage the condition and its related complications. Some of the ...

Young people with sickle cell disease (SCD) who live in areas with more air pollution are more likely to be hospitalized due to acute chest syndrome (ACS), an SCD complication marked by symptoms that ...